New recommendations in the care of pediatric and adolescent patients with tuberculosis Official opinion of the Children’s Pulmonology Society ČLS JEP and the Society for Pneumology and Phthisiology ČLS JEP
Authors:
Doležalová Karolína 1; Vašáková Koziar Martina 2; Pohunek Petr 3
Authors place of work:
Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní, Thomayerova nemocnice, Praha
1; Pneumologická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní, Thomayerova nemocnice, Praha
2; Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní, nemocnice Motol, Praha
3
Published in the journal:
Čes-slov Pediat 2024; 79 (Supplementum 1): 25-35.
Category:
doi:
https://doi.org/10.55095/CSPediatrie2024/031
Summary
The new recommendations are a follow-up to the 2012 Standard treatment guidelines(1) and the 2016 special issue of Czech-Slovak Paediatrics dedicated to tuberculosis (TB).(2)
The present document reflects the new recommendations(3) of the World Health Organization (WHO), which has long been seeking new strategies for optimal treatment of paediatric and adolescent patients, as more than 10 million people worldwide develop TB annually, including 1.2 million children.(4) In the Czech Republic, TB remains a rare disease, with an incidence of 3.6/100,000 in 2022.(5) Childhood TB mirrors the trend of adult TB. Between 2010–2020, the trend was downward. Even the change in vaccination strategy in 2010 did not change this trend.(6) From 2021, we observe a slight increase in paediatric TB cases. In 2023, 29 children developed TB (Figure 1).
The increase in paediatric TB cases, including treatment-resistant forms, makes it imperative to update recommendations for diagnosis and treatment in line with global trends. In particular, the main changes to the recommended approach relate to shortening treatment of uncomplicated TB in children aged 3-16 years to 4 months. There are also newly defined groups of drug-resistant (DR) TB and a new strategy for their treatment, which includes the administration of bedaquiline and delamanid. The introduction of TB preventive therapy for contacts of DR-TB is also innovative.
Keywords:
diagnosis – tuberculosis – therapy – resistant forms – treatment strategy
Zdroje
1. Křepela K, Kolek V, Koziar Vašáková M, Pohunek P. Komplexní péče o tuberkulózu dětí a mladistvých v ČR. Standard diagnostického a léčebného plánu. Studia pneumologica et phtiseologica 2012; 72(6): 297–302.
2. Česko-slovenská pediatrie 2016; 7–8. [Online.] Dostupné na: https://www.prolekare.cz/casopisy/cesko-slovenska-pediatrie/archiv-cisel/2016-7-8
3. WHO operational handbook on tuberculosis: module 5: management of tuberculosis in children and adolescents. [Online.] Dostupné na: //www.who.int/publications/i/item/9789240046832
4. TB incidence. [Online.] Dostupné na: https: //www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-disease-burden/1-1-tb-incidence
5. Basic Overview of Tuberculosis Epidemiology in the Czech Republic in 2022. [Online.] Dostupné na: https://tbc.uzis.cz/
6. Dolezalová K, Göpfertová D. Ten Years’ Experience with the discontinuation of the Bacillus Calmette-Guérin vaccination in the Czech Republic. Int J Mycobacteriol 2021; 10(2): 193–8.
7. World Health Organization. WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents.
8. Lancella L, Vecchio AL, Chiappini E, et al. How to manage children who have come into contact with patients affected by tuberculosis. J Clin Tuberc Other Mycobact Dis 2015.
9. Baguma R, Mbandi SK, Rodo MJ, et al. Inflammatory determinants of differential tuberculosis risk in pre-adolescent children and young adults. Front Immunol 2021; 12: 639965.
10. Snow KJ, Cruz AT, Seddon JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health 2020; 4(1).
11. Buonsenso D, Pata D, Visconti E, et al. Chest CT scan for the diagnosis of pediatric pulmonary TB: radiological findings and its diagnostic significance. Front Pediatr 2021; 9: 583197.
12. Veedu PT, Bhalla AS, Vishnubhatla S, et al. Pediatric vs adult pulmonary tuberculosis: A retrospective computed tomography study. World J Clin Pediatr 2013; 2(4): 70.
13. Sali M, Buonsenso D, Goletti D, et al. Accuracy of QuantiFERON-TB gold test for tuberculosis diagnosis in children. PLoS One 2015; 10(10).
14. Soler-Garcia A, Gamell A, Santiago B, et al. Diagnostic accuracy of QuantiFERON-TB Gold Plus Assays in children and adolescents with tuberculosis disease. J Pediatr 2020; 223: 212–215.e1.
15. Santin M, García-García JM, Rigau D, et al. Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection. Enferm Infecc Microbiol Clin 2016; 34(5): 304–8.
16. Seddon JA, Jenkins HE, Liu L, et al. Counting Children with Tuberculosis: Why Numbers Matter. Int J Tuberc Lung Dis 2015; 19(1): 9.
17. Brent AJ, Mugo D, Musyimi R, et al. Bacteriological diagnosis of childhood TB: a prospective observational study. Scientific Reports 2017; 7(1): 1–9.
18. Hatherill M, Hawkridge T, Zar HJ, et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child 2009; 94(3): 195–201.
19. Ntinginya NE, Squire SB, Millington KA, et al. Performance of the Xpert(R) MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania. Int J Tuberc Lung Dis 2012; 16(11): 1468–70.
20. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11(11): 819–24.
21. Statistics CH. European Union European Social Fund Operational Programme Employment Development of the NHIS Technology Platform Basic Overview of Tuberculosis Epidemiology in the Czech Republic in 2021. Dostupné na: www.uzis.cz
22. SHINE trial on shorter treatment for children with minimal TB. Dostupné na: https://www.who.int/news/item/26-10-2020-shine-trial-on-shorter-treatment-for-children-with-minimal-tb
23. Turkova A, Wills GH, Wobudeya E, et al. Shorter treatment for nonsevere tuberculosis in African and Indian children. N Engl J Med 2022; 386(10): 911–22.
24. Baquero-Artigao F, del Rosal T, Falcón-Neyra L, et al. Actualización del diagnóstico y tratamiento de la tuberculosis. An Pediatr (Engl Ed) 2023. Dostupné na: https://linkinghub.elsevier.com/retrieve/pii/S1695403323000802
25. Ryan H, Yoo J, Darsini P. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2017; 3.
26. Turnbull L, Bell C, Child F. Tuberculosis (NICE clinical guideline 33). Arch Dis Childhood Education Pract 2017; 102(3): 136–42.
27. Clinical Guidance.
28. Migliori GB, Tiberi S, Migliori GB. WHO drug-resistant TB guidelines 2022: what is new? Dostupné na: http://dx.doi.org/10.5588/ijtld.22.0263
29. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Dostupné na: https://www.who.int/publications/i/item/9789240063129
30. Burke RM, Nliwasa M, Feasey HRA, et al. Community-based active case-finding interventions for tuberculosis: a systematic review. Lancet Public Health 2021; 6(5): e283–99.
31. WHO. Latent TB Infection: Updated and consolidated guidelines for programmatic management. 2019. Dostupné na: http://www.who.int/tb/publications/2018/latent-tuberculosis-infection/en/
32. Marks SM, Mase SR, Morris SB. Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis. Clin Infect Dis 2017; 64(12): 1670–7.
33. Migliori GB, Wu SJ, Matteelli A, et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberculosis Lung Dis 2022; 26(3): 190.
34. Wasserman S, Furin J. Clarity with INHindsight: High-dose isoniazid for drug-resistant tuberculosis with inhA mutations. Am J Respir Crit Care Med 2020; 201(11): 1331–3.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2024 Číslo Supplementum 1
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Meningococcal infections in childhood
- New recommendations in the care of pediatric and adolescent patients with tuberculosis Official opinion of the Children’s Pulmonology Society ČLS JEP and the Society for Pneumology and Phthisiology ČLS JEP
- Meningococcus in practice – why is prevention important?
- Prevention options of pneumococcal disease in children